Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 3316 AL 3330

Sensory-Based Interventions for Adults with Dementia and Alzheimer's Disease: A Scoping Review

Smith BC, D'Amico M.

Occup Ther Health Care. 2020 Jul;34(3):171-201. doi: 10.1080/07380577.2019.1608488. Epub 2019 May 8.

Natural Compounds for Alzheimer's Disease Therapy: A Systematic Review of Preclinical and Clinical Studies

Andrade S, Ramalho MJ, Loureiro JA, Pereira MDC.

Int J Mol Sci. 2019 May 10;20(9):2313. doi: 10.3390/ijms20092313.

Development and validation of Alzheimer's Disease Animal Model for the Purpose of Regenerative Medicine

Goodarzi P, Payab M, Alavi-Moghadam S, Larijani B, Rahim F, Bana N, Sarvari M, Adibi H, Foroughi Heravani N, Hadavandkhani M, Arjmand B.

Cell Tissue Bank. 2019 Jun;20(2):141-151. doi: 10.1007/s10561-019-09773-8. Epub 2019 May 13.

NQO1: A target for the treatment of cancer and neurological diseases, and a model to understand loss of function disease mechanisms

Beaver SK, Mesa-Torres N, Pey AL, Timson DJ.

Biochim Biophys Acta Proteins Proteom. 2019 Jul-Aug;1867(7-8):663-676. doi: 10.1016/j.bbapap.2019.05.002. Epub 2019 May 12.

Tau immunotherapies for Alzheimer's disease

Hoskin JL, Sabbagh MN, Al-Hasan Y, Decourt B.

Expert Opin Investig Drugs. 2019 Jun;28(6):545-554. doi: 10.1080/13543784.2019.1619694. Epub 2019 May 22.

Tackling Alzheimer's disease: Hypothetical synergism between anti-inflammatory and anti-diabetic agents

Łuc M, Woźniak M, Helemejko M, Rymaszewska J.

Life Sci. 2019 Aug 15;231:116483. doi: 10.1016/j.lfs.2019.05.039. Epub 2019 May 15.

Multi-target design strategies for the improved treatment of Alzheimer's disease

Zhang P, Xu S, Zhu Z, Xu J.

Eur J Med Chem. 2019 Aug 15;176:228-247. doi: 10.1016/j.ejmech.2019.05.020. Epub 2019 May 11.

Challenges in the treatment of Alzheimer's disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors

Kuo YC, Rajesh R.

Expert Rev Neurother. 2019 Jul;19(7):623-652. doi: 10.1080/14737175.2019.1621750. Epub 2019 May 29.

Plasma Replacement Therapy for Alzheimer's Disease

Ding XL, Lei P.

Neurosci Bull. 2020 Jan;36(1):89-90. doi: 10.1007/s12264-019-00394-5. Epub 2019 May 20.

A good marker does not mean a good target for clinical trials in Alzheimer's disease: the amyloid hypothesis questioned

Modrego P, Lobo A.

Neurodegener Dis Manag. 2019 Jun;9(3):119-121. doi: 10.2217/nmt-2019-0006. Epub 2019 May 22.

Neuroprotective effects of berberine in animal models of Alzheimer's disease: a systematic review of pre-clinical studies

Yuan NN, Cai CZ, Wu MY, Su HX, Li M, Lu JH.

BMC Complement Altern Med. 2019 May 23;19(1):109. doi: 10.1186/s12906-019-2510-z.

Effects of Vitamin D Use on Outcomes of Psychotic Symptoms in Alzheimer Disease Patients

Wang L, Ying J, Fan P, Weamer EA, DeMichele-Sweet MAA, Lopez OL, Kofler JK, Sweet RA.

Am J Geriatr Psychiatry. 2019 Sep;27(9):908-917. doi: 10.1016/j.jagp.2019.03.016. Epub 2019 Mar 27.

[Drug treatment of Alzheimer's dementia : Status quo and perspectives]

Müller P, Fendt M, Müller NG.

Internist (Berl). 2019 Jul;60(7):761-768. doi: 10.1007/s00108-019-0625-4.

Alzheimer's disease: future drug development and the blood-brain barrier

Pardridge WM.

Expert Opin Investig Drugs. 2019 Jul;28(7):569-572. doi: 10.1080/13543784.2019.1627325. Epub 2019 Jun 4.

Lithium as a Treatment for Alzheimer's Disease: The Systems Pharmacology Perspective

Hampel H, Lista S, Mango D, Nisticò R, Perry G, Avila J, Hernandez F, Geerts H, Vergallo A; Alzheimer Precision Medicine Initiative (APMI).

J Alzheimers Dis. 2019;69(3):615-629. doi: 10.3233/JAD-190197.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias